Cytokinetics is a California-based biopharmaceutical company that researches and develops muscle activators and muscle inhibitors to treat cardiovascular diseases...
Read moreCytokinetics is a California-based biopharmaceutical company that researches and develops muscle activators and muscle inhibitors to treat cardiovascular diseases...
Read more1998
PublicIndependent CompanyNASDAQCYTK
Annual Revenue
$148.2M
Cytokinetics's revenue is the ranked 8th among it's top 10 competitors. The top 10 competitors average 18.8B. Over the last four quarters, Cytokinetics's revenue has decreased by 95.5%. Specifically, in Q3 2022's revenue was $2.5M; in Q2 2022, it was $89M; in Q1 2022, it was $1.1M; in Q4 2021, Cytokinetics's revenue was $55.6M.